Methanandamide: Difference between revisions
Content deleted Content added
m remove Erik9bot category,outdated, tag and general fixes |
حسن علي البط (talk | contribs) m Removed Category:Carboxylate esters (using HotCat) |
||
| Line 25: | Line 25: | ||
{{Cannabinoids}} |
{{Cannabinoids}} |
||
[[Category:Carboxylate esters]] |
|||
[[Category:Amides]] |
[[Category:Amides]] |
||
[[Category:Cannabinoids]] |
[[Category:Cannabinoids]] |
||
Revision as of 06:59, 7 April 2010
 |
| File:Methanandamide.png | |
| Clinical data | |
|---|---|
| Other names | AM-356, arachidonyl-1'-hydroxy-2'-propylamide |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C23H39NO2 |
| Molar mass | 361.561 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
Methanandamide, or N-(2-hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide, is a synthetically created stable chiral analog of anandamide. Its effects have been observed to act on the cannabinoid receptors (specifically on CB1 receptors, which are part of the central nervous system) found in different organisms such as mammals, fish, and certain invertebrates (e.g. Hydra).
.svg){kind=small} | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
 | This article about an organic compound is a stub. You can help Wikipedia by expanding it. |